Terns Pharmaceuticals Inc — Financial Statements (NASDAQ:TERN) | MetaTrader

Open full chart

뉴스

Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.

Merck & Co.'s Quarterly Earnings Preview: What You Need to Know

AZN vs. MRK: Which Oncology Stock Offers Better Investment Potential?

Biotech Is Holding Steady In 2026 (NASDAQ:IBB)

Stock Market Breaks Lower As Oil Prices Rebound Amid Iran War; Arm Flexes: Weekly Review

Can MRK's Ongoing M&A Push Aid Long-Term Growth Ahead of Keytruda LOE?

Merck Stock Soars 50% in 6 Months: Buy, Hold, or Take Profits?

Merck to Boost Oncology Pipeline With $6.7B Terns Buyout, Stock Up

Merck's Deal For Terns And Its Stellar CML Drug Candidate Looks Like Good Business (MRK)

Why Merck Might Have A Fight On Its Hands With Its $6.7 Billion Takeover Of Terns

Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal

Merck Chases $6B Terns Pharma Deal to Boost Cancer Pipeline — Is Keytruda’s Expiry Driving the Panic? - TipRanks.com